Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers

Neutral

AI Analysis

Summary

Alphabet and Meta combined spent $118.5 billion on R&D in 2025, approaching the $123.7 billion spent by the 10 largest pharmaceutical companies, highlighting the increasing R&D investment by technology companies in life sciences.

Importance:2/10

Sentiment:

0.00

R&D spendingBig TechBig Pharmacompetitive landscape2025 financials

Related Companies

$JNJ $RHHBY

Read the original article

Published by Drug Discovery & Development on September 24, 2026 10:31 PM

Read Original